CRY
$28.70
Cryolife
($.88)
(2.97%)
CRY
Earnings Whisper ®
N/A
4th Quarter December 2018
Consensus:  $0.12
Revenue:  $67.10 Mil
Wednesday
Jan 30
5:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Wednesday, October 31, 2018

What do you expect when CRY reports earnings?
Beat
Meet
Miss

Where is CRY's stock price going from here?
Up
Flat
Down
Stock chart of CRY
Analysts
Summary of analysts' recommendations for CRY
Score
Grade
Pivots
Resistance
$30.70
$30.27
$29.48

$29.05

Support
$28.26
$27.83
$27.04
Tweet
Growth
Description
CryoLife, Inc. is the leader in the development and commercialization of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The company's BioGlue surgical adhesive, the company marked in the European Union for use in vascular and pulmonary sealing and repair, is distributed throughout Europe. The company also manufactures CryoLife- O'Brien and CryoLife-Ross stentless porcine heart valves which are distributed within the European Community. (PRESS RELEASE)
Peers
Edwards LifesciencesIntuitive SurgicalAlign TechnologyWright Medical GroupSTERISInvacareRTI SurgicalLakeland Industries